The COVID-19 vaccine developed by AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said on Sunday, according to AFP.
The vaccine provides "100 per cent protection" against severe COVID-19 disease requiring hospitalization, Pascal Soriot said in an interview with the Sunday Times newspaper.